CWM
PACB icon

CIBC World Markets’s Pacific Biosciences PACB Stock Holding History

CIBC World Markets’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$34.2K Buy
+18,268
New +$35.1K ﹤0.01% 1211
2025
Q2 		$42.2K Sell
34,023
-26,674
-44% -$30.8K ﹤0.01% 1488
2025
Q1 		$71.6K Buy
60,697
+35,097
+137% +$53.8K ﹤0.01% 1663
2024
Q4 		$46.8K Buy
+25,600
New +$50K ﹤0.01% 1261

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Markets's PACB Position: Q4 2025 in Review

CIBC World Markets opened a new position in Pacific Biosciences (PACB) in Q4 2025: 18,268 shares worth $34.2K. The stake represents ﹤0.01% of the portfolio and ranks #1211 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in PACB as recently as Q2 2025.

CIBC World Markets first reported a position in PACB in Q4 2024 and has held it in 4 quarters since. The position peaked at $71.6K in Q1 2025. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • CIBC World Markets held 18,268 shares of Pacific Biosciences worth $34.2K as of Q4 2025.
  • Pacific Biosciences was a new CIBC World Markets position in Q4 2025.
  • Pacific Biosciences made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1211 holding.
  • CIBC World Markets first reported a position in Pacific Biosciences in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Pacific Biosciences position peaked at $71.6K in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.